Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CSBR | Common Stock | Options Exercise | $26.5K | +16.7K | +2.23% | $1.59 | 765K | Oct 15, 2021 | Direct | |
transaction | CSBR | Common Stock | Tax liability | $26.5K | +2.63K | +0.35% | $10.08 | 762K | Oct 15, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CSBR | Option to purchase Common Stock | Award | $0 | +16.7K | $0.00* | 0 | Oct 15, 2021 | Common Stock | 16.7K | $1.59 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents a "net exercise" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on October 15, 2021. |
F2 | The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017, respectively. |